𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma

✍ Scribed by P.J.M. Kil; H.M.J. Goldschmidt; B.J.A. Wieggers; O.B. Kariakine; U.E. Studer; P. Whelan; J. Hetherington; Th.M. de Reijke; J.W. Hoekstra; L. Collette

Book ID
114218514
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
286 KB
Volume
43
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Measurements of free and total PSA, tiss
Measurements of free and total PSA, tissue polypeptide-specific antigen (TPS), and CYFRA 21-1 in prostate cancer patients under intermittent androgen suppression therapy
✍ Theyer, Gerhard; DοΏ½rer, Alexander; Theyer, Ulrike; Haberl, Ines; Ulsperger, Erns πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 2 views

BACKGROUND. The present study evaluated monthly measurements of free and total prostate-specific antigen (PSA), and the tumor proliferation markers tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 21-1 (CYFRA 21-1) in patients with advanced prostate cancer receiving intermittent an